Authors:
KOBER L
TORPPEDERSEN C
CARLSEN JE
BAGGER H
ELIASEN P
LYNGBORG K
VIDEBEK J
COLE DS
AUCLERT L
PAULY NC
ALIOT E
PERSSON S
CAMM AJ
Citation: L. Kober et al., A CLINICAL-TRIAL OF THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR TRANDOLAPRIL IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION, The New England journal of medicine, 333(25), 1995, pp. 1670-1676
Citation: Jhb. Debruijn et al., EFFICACY AND TOLERANCE OF TRANDOLAPRIL (0.5-2-MG) ADMINISTERED FOR 4 WEEKS IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000060-190000064
Citation: Nc. Pauly et Me. Safar, COMPARISON OF THE EFFICACY AND SAFETY OF TRANDOLAPRIL AND CAPTOPRIL FOR 16 WEEKS IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000073-190000076
Citation: Bh. Meyer et Nc. Pauly, DOUBLE-BLIND COMPARISON OF THE EFFICACY AND SAFETY OF TRANDOLAPRIL 2-MG AND HYDROCHLOROTHIAZIDE 25-MG IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000077-190000080
Citation: G. Steiner et Nc. Pauly, COMPARISON OF THE EFFICACY AND SAFETY OF TRANDOLAPRIL AND NIFEDIPINE SR IN MILD-TO-MODERATE HYPERTENSION, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000081-190000085
Citation: Ci. Backhouse et al., LONG-TERM THERAPY WITH TRANDOLAPRIL, A NEW NONSULFHYDRYL ACE-INHIBITOR, IN HYPERTENSION - A MULTICENTER INTERNATIONAL TRIAL, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000086-190000090